Back to Results
First PageMeta Content
Chemistry / Organic chemistry / Cancer / RTT / PARP inhibitors / Lactams / Indoles / Olaparib / Piperazines / Cediranib / AstraZeneca / Ovarian cancer


Press Release VOLUNTIS AND ASTRAZENECA TO TEST COMPANION MOBILE APP IN OVARIAN CANCER STUDIES WITH THE US NATIONAL CANCER INSTITUTE 7 December 2015 Voluntis and AstraZeneca today announced plans to test a digital support
Add to Reading List

Document Date: 2015-12-14 07:38:32


Open Document

File Size: 466,45 KB

Share Result on Facebook